Visalytics
Visalytics
approved EB-2 (NIW)

Research Assistant

Biostatistics · China · 2024-10-31

Processing Time
49 days
Decision Date
2024-10-31
Location
Florida
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research on developing innovative statistical methodologies that enhance the precision, efficiency, and reliability of clinical trials. Her work focuses on improving therapeutic outcomes, reducing costs and time for bringing treatments to market, and increasing the accessibility of life-saving treatments to reduce the U.S. disease burden.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research on clinical trial methodologies aims to reduce the U.S. disease burden and is supported by the National Institute on Drug Abuse.

2 Well-positioned to Advance the Endeavor Met

The petitioner's advanced degree, publication record in the top 1% and 10% of her field, and 84 citations demonstrate her influence and expertise.

3 Waiver Benefit Met

The petitioner's work in enhancing the efficiency of bringing life-saving treatments to market provides a benefit that outweighs the need for a labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's M.S. in Biostatistics and a strong record of 84 citations. She authored multiple papers, including one in the top 1% and three in the top 10% of most-cited articles in her field, and completed at least one peer review for a reputable journal. The case was supported by 2 expert recommendation letters and evidence of funding from the National Institute on Drug Abuse (NIDA).

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Judging Experience
Government Alignment

Similar Cases

Statistician

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
New Jersey 50 days 2025-03-09
The petitioner proposes to enhance the design and analysis of clinical trials through advanced statistical methodologies and machine learning. His work focuses on creating innovative tools that optimize clinical trial accuracy and accelerate therapeutic approvals for oncology, cardiovascular diseases, and infectious diseases. This endeavor aims to improve public health outcomes by ensuring regulatory compliance and addressing safety evaluation challenges in complex medical conditions.
View Case

Postdoctoral Researcher

Research and Development · China

WeGreened EB-2 (NIW) approved
North Carolina 7 days 2024-07-22
The petitioner proposes to research methods for integrating and analyzing multiple high-dimensional datasets from clinical trials, electronic health records, and large distributed research networks. This work aims to enhance diagnostic accuracy, personalize treatment plans, and address public health disparities by strengthening the data yielded by clinical studies.
View Case

Research Scientist

Research and Development · China

WeGreened EB-2 (NIW) approved
Massachusetts 151 days 2025-02-27
The petitioner proposes to refine statistical methodologies for experimental and observational studies to improve the quality of clinical data interpretation. Her work focuses on enhancing the reliability of healthcare research across various disease contexts, specifically ensuring that real-world evidence from large-scale datasets is evaluated with scientific rigor.
View Case

General Manager

Research and Development · China

WeGreened EB-2 (NIW) approved
Washington 390 days 2025-02-05
The petitioner proposes to develop novel statistical approaches to facilitate drug development, healthcare, and pandemic prevention for public health improvement. This includes drafting statistical analysis plans and protocols for clinical trials, as well as implementing statistical techniques for primary endpoints analysis and data monitoring.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-10-31.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 49 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist